Keyword: Relay Therapeutics

Total annual biotech investments

Biotech's top 10 money raisers of 2018

Private biotechs raised a record-breaking $16.8 billion in 2018, blowing past the record $12.1 billion set the previous year. Here are the top 10 fundraising rounds—which broke some records themselves and together illustrate what's hot out there in the field.

Relay Therapeutics

Because proteins move constantly inside cells, Relay’s A-list founders and investor Third Rock Ventures think showing motion will reveal new ways to treat diseases. The first step is to go after the many frequently mutated oncogenes the industry is yet to drug.